130 related articles for article (PubMed ID: 2840187)
21. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
Zeng L
Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
[TBL] [Abstract][Full Text] [Related]
22. [Studies on antigen associated with human squamous cell carcinoma (SCC antigen) in patients with esophageal carcinoma].
Hirata S; Yamazaki K; Yokoyama Y; Ueda M; Kubo Y; Samejima N
Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):267-72. PubMed ID: 2747608
[TBL] [Abstract][Full Text] [Related]
23. Squamous cell carcinoma antigen (TA-4) in penile carcinoma.
Wishnow KI; Johnson DE; Fritsche H
Urology; 1990 Oct; 36(4):315-7. PubMed ID: 2219609
[TBL] [Abstract][Full Text] [Related]
24. [Determination of the SCC antigen in the serum of patients with cervical cancer].
Crombach G; Würz H; Bolte A
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
[TBL] [Abstract][Full Text] [Related]
25. The use of a tumor antigen TA-4 for the management of squamous cell carcinoma.
Kato H; Tamai K; Nagaya T; Nagai M; Torigoe T
Cancer Detect Prev; 1985; 8(1-2):155-9. PubMed ID: 4064035
[TBL] [Abstract][Full Text] [Related]
26. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
[TBL] [Abstract][Full Text] [Related]
27. [The clinical evaluation of the serum SCC antigen levels with "SCC RIABEAD" by immunoradiometric assay].
Yoshida Y; Takashima H; Kawasaki Y; Yasuda S; Tamai T; Hosokawa N; Miyamoto T; Matuno S; Sakamoto K; Nakase S
Radioisotopes; 1988 Sep; 37(9):525-8. PubMed ID: 3194547
[TBL] [Abstract][Full Text] [Related]
28. Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva.
van der Sijde R; de Bruijn HW; Krans M; Bouma J; Aalders JG
Gynecol Oncol; 1989 Nov; 35(2):227-32. PubMed ID: 2807015
[TBL] [Abstract][Full Text] [Related]
29. Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma.
Nikliński J; Chyczewska E; Furman M; Kowal E; Kozłowski M
Neoplasma; 1992; 39(5):283-5. PubMed ID: 1331827
[TBL] [Abstract][Full Text] [Related]
30. Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma.
Kato H; Tamai K; Morioka H; Nagai M; Nagaya T; Torigoe T
Cancer; 1984 Oct; 54(8):1544-6. PubMed ID: 6478396
[TBL] [Abstract][Full Text] [Related]
31. Squamous cell carcinoma antigen in lung cancer and nonmalignant respiratory diseases.
Kagohashi K; Satoh H; Kurishima K; Kadono K; Ishikawa H; Ohtsuka M; Sekizawa K
Lung; 2008; 186(5):323-6. PubMed ID: 18663529
[TBL] [Abstract][Full Text] [Related]
32. TA 4-SCC versus CEA sensitivity for lung cancer.
Pecchio F; Rapellino M; Ricci E; Casadio C; Moscato D; Adamo R; Miserendino L; Sansalvadore F
Tumori; 1988 Aug; 74(4):393-5. PubMed ID: 2847383
[TBL] [Abstract][Full Text] [Related]
33. [An immunoradiometric assay of serum SCC antigen using a monoclonal antibody--a comparison with the conventional double antibody method].
Mino N; Iio A; Ata M; Hamamoto K
Gan No Rinsho; 1988 Mar; 34(3):321-5. PubMed ID: 3357252
[TBL] [Abstract][Full Text] [Related]
34. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
[TBL] [Abstract][Full Text] [Related]
35. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
Ogino I; Nakayama H; Okamoto N; Kitamura T; Inoue T
Int J Gynecol Cancer; 2006; 16(3):1094-100. PubMed ID: 16803491
[TBL] [Abstract][Full Text] [Related]
36. [Clinical value of SCC-antigen, a subfraction of tumor antigen TA-4, in the management of cervical cancer].
Kato H; Tamai K; Magaya T; Nagai M; Noguchi H; Suehiro Y; Torigoe T
Gan No Rinsho; 1985 May; 31(6 Suppl):594-9. PubMed ID: 4032751
[TBL] [Abstract][Full Text] [Related]
37. Squamous cell carcinoma antigen in the diagnosis and treatment follow-up of oral and facial squamous cell carcinoma.
Fischbach W; Meyer T; Barthel K
Cancer; 1990 Mar; 65(6):1321-4. PubMed ID: 2306680
[TBL] [Abstract][Full Text] [Related]
38. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
Esajas MD; Duk JM; de Bruijn HW; Aalders JG; Willemse PH; Sluiter W; Pras B; ten Hoor K; Hollema H; van der Zee AG
J Clin Oncol; 2001 Oct; 19(19):3960-6. PubMed ID: 11579117
[TBL] [Abstract][Full Text] [Related]
39. SCC tumour marker and its relationship to clinical stage in squamous cervical cancer.
Henry RJ; Dodd JK; Tyler JP; Houghton CR
Aust N Z J Obstet Gynaecol; 1987 Nov; 27(4):338-40. PubMed ID: 3453675
[TBL] [Abstract][Full Text] [Related]
40. [Clinical and fundamental study of a squamous cell carcinoma related antigen (SCC-RA) for esophageal squamous cell carcinoma].
Ikeda K
Nihon Geka Gakkai Zasshi; 1991 Apr; 92(4):387-96. PubMed ID: 1870566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
